VRX--CEPH; GSK--HGSI; I am sure Next will be EXEL
Many big drug companies have their drug patent expired soon, they hold over $70 billions to look for takeover candidate. 2011 & 2012 average takeover deal wwas 250 per year!!! Thinking about EXEL has over 30 drug candidates and enough cash! I believe EXEL will follow CEPH and HGSI.
Sentiment: Strong Buy